New Host
After much frustration with the previous blog host for BiotechBlog, we’ve now moved to a new home at WordPress. Initial […]
After much frustration with the previous blog host for BiotechBlog, we’ve now moved to a new home at WordPress. Initial […]
This blog post and the ensuing discussion present an interesting and revealing dialogue on the practicality of creating an open
HGS recently completed a $225 million factory to make products that still don’t exist…
Will Human Genome Sciences finally be able to manufacture something in its new plant? Read Post »
An investigation conducted by the U.S. Food and Drug Administration found a significant percentage of drugs touted as Canadian and
The California-based Scripps Research Institute has told Palm Beach County commissioners that it now prefers to build its planned biotechnology
Scripps Institute proposes new Florida site for biotech park Read Post »
With the US in regulatory limbo, Europe is winning the race to be the first regulated drugs market to approve
Intellectual Property: Last chance for Europe’s biotech pioneers Read Post »
Offshoring labor to countries with cheaper labor and relaxed regulatory schemes has devastated industries such as textiles and manufacturing –
The biotech sector saw a significant run-up last month, but for at least one analyst, questions remain about what the